KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Debt Ratio (2016 - 2025)

Inovio Pharmaceuticals' Debt Ratio history spans 16 years, with the latest figure at 0.17 for Q2 2025.

  • For Q2 2025, Debt Ratio changed N/A year-over-year to 0.17; the TTM value through Jun 2025 reached 0.17, changed N/A, while the annual FY2024 figure was 0.12, 19.36% up from the prior year.
  • Debt Ratio for Q2 2025 was 0.17 at Inovio Pharmaceuticals, up from 0.11 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.17 in Q2 2025 and bottomed at 0.0 in Q3 2021.
  • The 5-year median for Debt Ratio is 0.0 (2023), against an average of 0.05.
  • The largest annual shift saw Debt Ratio crashed 49.46% in 2021 before it surged 2360.46% in 2023.
  • A 5-year view of Debt Ratio shows it stood at 0.0 in 2021, then skyrocketed by 277.2% to 0.0 in 2022, then soared by 2253.6% to 0.1 in 2023, then increased by 19.36% to 0.12 in 2024, then soared by 42.92% to 0.17 in 2025.
  • Per Business Quant, the three most recent readings for INO's Debt Ratio are 0.17 (Q2 2025), 0.11 (Q1 2025), and 0.12 (Q4 2024).